The results showed that there is higher TP53INP2 expression in OCI-AML3 cells with NPM1 mutation type A(NPM1-mA) compared to other leukemia cell lines without NPM1-mA (Figure 2A). This evidence concerns the gene TP53INP2 and leukemia.